Report
EUR 236.14 For Business Accounts Only

A flat revenues growth.

Julphar recorded Q4 2015 net profit increase of 4.8% to AED79.1m (vs. AED75.5m in the same period of 2014). FY2015 consolidated sales reached AED1439.8m, a weak organic growth of 0.5% compared to 2014. The operating income grew by 13.6% to AED271m, setting the operating margin at 18.8%, and bringing the annual net profit to AED243.5m, an increase of 3.75% compared to 2014. Thus the net margin stood at 17% (vs. 16.4% in the previous year).
Underlying
Gulf Pharmaceutical Industries

Provider
AlphaMena Corporate Services
AlphaMena Corporate Services

AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.

Other Reports on these Companies
Other Reports from AlphaMena Corporate Services

ResearchPool Subscriptions

Get the most out of your insights

Get in touch